Sinopharm Group Co Ltd
XBER:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
XBER:X2S
|
CN |
|
Toyota Boshoku Corp
F:TY7
|
JP |
|
E
|
Expedia Group Inc
F:E3X1
|
US |
|
P2Earn Inc
F:WH4
|
CA |
|
Zinc One Resources Inc
F:RH3
|
CA |
|
E
|
EDP Energias de Portugal SA
XBER:EDP
|
PT |
|
T
|
Tokyo Gas Co Ltd
DUS:TOG
|
JP |
|
D
|
Dios Fastigheter AB
F:D1F
|
SE |
|
Anabatic Technologies Tbk PT
IDX:ATIC
|
ID |
|
Peel Mining Ltd
ASX:PEX
|
AU |
|
C
|
Criteo SA
SWB:CI5A
|
FR |
|
Guangdong Investment Ltd
HKEX:270
|
HK |
|
V
|
Vocento SA
XMUN:VON
|
ES |
|
CNB Financial Corp
F:44I
|
US |
|
M
|
Mondi PLC
F:KYC0
|
UK |
|
C
|
Cushman & Wakefield PLC
F:2IY
|
UK |
|
M
|
MTI Investment SE
F:K8Y
|
SE |
|
T
|
Tyson Foods Inc
XMUN:TF7A
|
US |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
DUS:AIL
|
FR |
|
A
|
AstraZeneca PLC
XMUN:ZEGA
|
UK |
|
L
|
Laurent Perrier SA
XBER:LPE
|
FR |
|
Goodfellow Inc
F:O3Z
|
CA |
|
O
|
Opawica Explorations Inc
OTC:OPWEF
|
CA |
|
E
|
Easterly Government Properties Inc
F:E05
|
US |
Dividends
Dividend Yield
Sinopharm Group Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Sinopharm Group Co Ltd
X2S have decreased by 74%.
Payout Ratio
Sinopharm Group Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for X2S is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
X2S Price
Sinopharm Group Co Ltd
| Average Annual Return | 19.63% |
| Standard Deviation of Annual Returns | 50.92% |
| Max Drawdown | -42% |
| Market Capitalization | 53.1B EUR |
| Shares Outstanding | 3 120 656 000 |
| Percentage of Shares Shorted |
N/A
|
